Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN.
about
What is new in the management of rapidly progressive glomerulonephritis?Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond.Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression.Emerging therapies in immunoglobulin A nephropathy.Integrative network and transcriptomics-based approach predicts genotype- specific drug combinations for melanoma.Lupus nephritis and B-cell targeting therapy.ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.Primary IgA nephropathy: current challenges and future prospects.New insights into the pathogenesis of IgA nephropathy.Myeloid cell-mediated renal injury in rapidly progressive glomerulonephritis depends upon spleen tyrosine kinase.Spleen tyrosine kinase contributes to acute renal allograft rejection in the rat.siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth.Antineutrophil cytoplasmic antibody associated vasculitides with renal involvement: Open challenges in the remission induction therapy.An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis.Anti-Glomerular Basement Membrane Disease.Role of the Spleen Tyrosine Kinase Pathway in Driving Inflammation in IgA Nephropathy
P2860
Q28259540-13673197-A128-41A2-B1F6-5BBDA585C1B5Q33620537-A24BDCBF-C5FD-4917-A2CB-531613E431B4Q35809151-3C12886E-428C-48A4-B4AD-DDF83EFD8739Q38511505-3B68E22D-74FE-486A-89DF-11F3FD4F6AE5Q38621140-164E498C-3F54-436D-AEDE-01B1B38F47B0Q38643755-B4564CD8-AF99-4AB8-9E5D-83947FF2E9C7Q49215238-250FFD33-CF6F-4232-882E-A115CE51CA5CQ52309425-481C3107-1FCE-431D-9206-051D424B2339Q53214093-9816F113-B763-489A-994C-F5313D1DD9F5Q53387884-8D1DFD4F-FF16-4DBD-A6B0-6A6E68CE2994Q53656379-23C3A3F0-1D78-44F4-B600-481E92F90F8CQ55317227-0A1857E3-2BF5-4684-AABA-815219D6B425Q55340553-B21CDD6A-B4E4-45F0-ADFC-3B93EAFE51FFQ55442953-B0C23823-5AC8-4142-B982-0C57A4D29CEEQ55508549-40ADC598-F73B-45D0-B18C-BF1A3516CA96Q58775138-2805624E-6093-42E5-8A3E-35C2ACEEA473
P2860
Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Spleen tyrosine kinase inhibit ...... es experimental autoimmune GN.
@ast
Spleen tyrosine kinase inhibit ...... es experimental autoimmune GN.
@en
Spleen tyrosine kinase inhibit ...... es experimental autoimmune GN.
@nl
type
label
Spleen tyrosine kinase inhibit ...... es experimental autoimmune GN.
@ast
Spleen tyrosine kinase inhibit ...... es experimental autoimmune GN.
@en
Spleen tyrosine kinase inhibit ...... es experimental autoimmune GN.
@nl
prefLabel
Spleen tyrosine kinase inhibit ...... es experimental autoimmune GN.
@ast
Spleen tyrosine kinase inhibit ...... es experimental autoimmune GN.
@en
Spleen tyrosine kinase inhibit ...... es experimental autoimmune GN.
@nl
P2093
P2860
P356
P1476
Spleen tyrosine kinase inhibit ...... es experimental autoimmune GN.
@en
P2093
Anisha Tanna
Charles D Pusey
Esteban S Masuda
Frederick W K Tam
Gurjeet Bhangal
H Terence Cook
Jennifer Smith
John P McDaid
John Reynolds
P2860
P304
P356
10.1681/ASN.2013090978
P577
2014-04-03T00:00:00Z